Fabrizio Montecucco, after obtaining his M.D. degree from the University of Genoa, Genoa, Italy, studied internal medicine at San Martino Hospital, Genoa, Italy, and University of Genoa, becoming a Specialist in 2008. Then, he moved for Postdoctoral Fellowship at the Laboratory of Professor François Mach, University of Geneva, Geneva, Switzerland, till present. Montecucco (h‐index 19) has large experience in the research field of atherosclerosis and acute ischemic events. From 2010 to 2012, he was the Scientific Head of clinic at the Cardiology Division, the University of Geneva. Then, in 2012, he became an Assistant Professor at the Department of Internal Medicine, the University of Genoa. After obtaining an unpaid license from the same university, he moved back to Geneva to continue his research work at the Department of Genetics and Laboratory Medicine and Division of Cardiology (under direction of Dr. Nicolas Vuilleumier and Professor François Mach). In 2014, he became Vice President of the European Society of Clinical Investigation (ESCI). Montecucco is the author of more than 140 publications with high impact factor, and during his career he has already obtained more than 2 million Euros as research grants. In 2008 and 2013, he participated as a Deputy of the Principal Investigator at European Collaborative Frame Program (7 projects) on inflammation and vascular wall remodelling in atherosclerosis (AtheroRemo) and targeting and exploiting B-cell function for treatment in cardiovascular disease (Athero‐B‐Cell). In 2011 and 2014, he obtained two Swiss National Science Foundation Grants on the pathophysiology of atherogenesis and cardiovascular diseases (no. 32003B_134963/1 and no. 310030_152639/1). In the last 10 years, he substantially contributed to better clarification of the inflammatory mechanisms underlying atherosclerosis and its acute dramatic complications, such as myocardial infarction and ischemic stroke in both human cohort and animal studies.
Biography Updated on 16 September 2014